In fact, our group demonstrated that mutation of all K residues within the cytosolic domain of APP leads to increased levels of CTFβ (Bustamante et al., 2013), an emerging pathogenic factor and a potential future biomarker for AD. This evidence concerns the gene APP and Alzheimer disease.